Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia

Haematologica

Volumn 89, Issue 6, 2004, Pages 664-670

  D'Alò, Francesco ^a   Voso, Maria Teresa ^a   Guidi, Francesco ^a   Massini, Giuseppina ^a   Scardocci, Alessandra ^a   Sica, Simona ^a   Pagano, Livio ^a   Hohaus, Stefan ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Acute myeloid leukemia; CYP1A1; Glutathione S transferase

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE; XENOBIOTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME POLYMORPHISM; FEMALE; GENE DELETION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 3042525107     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S. The CYP1A1 gene and cancer susceptibility. Critical Rev Oncol/Hematol 1993;14:77-87.
2. Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility: a review. Gene 1995;159:113-21.
3. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
4. el-Zein R, Conforti-Froes N, Au WW. Interactions between genetic predisposition and environmental toxicants for development of lung cancer. Environmental and molecular mutagenesis 1997;30:196-204.
5. Strange RC, Lear JT, Fryer AA. Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chemico-biological interactions 1998;111:351-64.
6. Salinas AE, Wong MG. Glutathione S-transferases-a review. Current medicinal chemistry 1999;6:279-309.
7. Sinnett D, Krajinovic M, Labuda D. Genetic susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 2000;38:447-62.
8. Krajinovic M, Ghadirian P, Richer C, Sinnett H, Gandini S, Perret C. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-enviroment interactions. Int J Canc 2001;92:220-5.
9. Ingelman-Sundberg M. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. Mut Res 2001;482:11-9.
10. Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, et al. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Haematologica 2003;88:1238-44.
11. Voso MT, D'Alò F, Putzulu R, Mele L, Scardocci A, Chiusolo P, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 2002;100:2703-7.
12. Butkiewicz D, Grzybowska E, Hemminki K, Ovrebo S, Haugen A, Motykiewicz G, et al. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms. Mutat Res 1998;415:97-108.
13. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 1990;263:131-3.
14. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated Mspl polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 1991;110:407-11.
15. Cascorbi I, Brockmöller J, Roots I. A C4887A polymorphysm in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Canc Res 1996;56:2965-9.
16. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 2000;13:193-207.
17. Kouides PA, Bennett JM. Morphology and classification of the myelodysplastic syndromes and their pathological variants. Semin Hematol 1996;33:95-110.
18. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998;92:2322-33.
19. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase τ 1 (GSTT1) gene defect. Lancet 1996;347:295-7.
20. Chen CL, Liu Q, Pui CH, Rivera GK, Sandlund JT, Ribeiro R, et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood 1997;89:1701-7.
21. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999;93:1496-501.
22. Roddam PL, Rollinson S, Kane E, Roman E, Moorman A, Cartwright R, et al. Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukemia. Pharmacogenetics 2000;10:605-15.
23. Preudhomme C, Nisse C, Hebbar M, Vanrumbeke M, Brizard A, Lai JL, et al. Glutathione S transferase τ 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens. Leukemia 1997;11:1580-2.
24. Sekine I, Saijo N. Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anti-cancer agents. Ann Oncol 2001;12:1515-25.
25. Matsuo T, Kuriyama K, Miyazaki Y, Yoshida S, Tomonaga M, Emi N, et al. The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype. Leukemia 2003;17:1538-43.
26. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes asssociated with susceptibility to lung cancer in relation to cigarette dose in Japanese population. Cancer Res 1993;53:2994-9.
27. Cavalieri EL, Rogan EG. A unified mechanism in the initiation of cancer. Ann N Y Acad Sci USA 2002;959:341-54.
28. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 1997;18:2307-11.
29. Bowen DT, Frew ME, Rollinson S, Roddam PL, Dring A, Smith MT, et al. Cytochrome P450 1A1*2B (Val) allele is over-represented in a sub-group of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication. Blood 2003;101:2770-4.
30. Osaka M, Koh T, Matsuo S, Sugiyama T. Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a] anthracene-induced rat leukemia. Mol Carcin 1997;18:206-12.
31. Nakagawa T, Saitoh S, Imoto S, Itoh M, Tsutsumi M, Hikiji K, et al. Multiple point mutations of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia. Oncology 1992;49:114-22.
32. Sasai Y, Horiike S, Misawa S, Kaneko H, Kobayashi M, Fujii H, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leukemia Research 1999;23:975-81.
33. Woo MH, Shuster JJ, Chen C, Bash RO, Behm FG, Camitta, B, et al. Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies. Leukemia 2000;14:232-7.
34. Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA 2001;98:11592-7.
35. Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000;6:4091-5.
36. Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA 1998;95:13176-81.
37. Rollinson S, Roddam P, Kane E, Roman E, Cartwright R, Jack A, et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukemia. Carcinogenesis 2000;21:43-7.
38. Davies SM, Robison LL, Buckley JD, Radloff GA, Ross JA, Perentesis JP. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study. Cancer Epidemiol Biomarkers Prev 2000;9:563-6.
39. Basu T, Gale RE, Langabeer S, Lynch DC. Glutathione S-transferase τ 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukemia. Lancet 1997;349:1450.
40. Atoyebi W, Kusec R, Fidler C, Peto TE, Boultwood J, Wainscoat JS. Glutathione S-transferase gene deletions in myelodysplasia. Lancet 1997;349:1450-1.
41. Crump C, Chen C, Appelbaum FR, Kopecky KJ, Schwartz SM, Willman CL, et al. Glutathione S-transferase τ 1 gene deletion and risk of acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev 2000;9:457-60.